Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 97 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
961 11.9 months Metastatic colorectal cancer 5 Chemotherapy
University Hospital Gasthuisberg Belgium 4/2011
Treatment Details: Patients: This phase II study involved previously treated metastatic colorectal cancer patients who were divided into two separate treatment groups. Group A consisted of 426 patients with
 
962 11.9 months Advanced melanoma 4 Immunotherapy
University of Minnesota United States 12/2012
Treatment Details: Patients: This phase 2 study involved advanced melanoma patients who were divided into two separate treatment groups. There were 11 patients in group A and 10 patients in group B. Age and
 
963 11.9 months Metastatic colorectal carcinoma 5 Biologic therapy
Chemotherapy
Antwerp University Hospital Belgium 2/2013
Treatment Details: Patients: This phase 2 study involved previously treated metastatic colorectal cancer patients who were separated into two treatment groups. Group A consisted of 95 patients with a median
 
964 11.9 months Advanced triple-negative breast cancer 4 Chemotherapy
Université Libre de Bruxelles Belgium 4/2014
Treatment Details: Patients: This phase 2 study involved female advanced triple-negative breast cancer (TNBC) patients who were divided into three separate treatment groups. Group A consisted of 55 patients
 
965 11.9 months Advanced NSCLC 4 Biologic therapy
Chemotherapy
Cross Cancer Institute Canada 12/2007
Treatment Details: Patients: This phase II study involved one hundred thirty one patients with advanced non-small-cell lung cancer. The median age was 66 years old, ranging from 35-84. Nineteen of the patie
 
966 11.9 months Recurrent GBM 3 Biologic therapy
Chemotherapy
Duke University Medical Center United States 2/2009
Treatment Details: Patients: This phase 2 trial involved 52 patients with recurrent glioblastoma multiforme, 30 males and 22 females. Patient age ranged from 25 to 69, with a median of 51.5. Treatment: P
 
967 11.9 months Advanced NSCLC 4 Chemotherapy
Tochigi Cancer Center Japan 6/2009
Treatment Details: Patients: This phase 2 study involved 40 patients with advanced non-small cell lung cancer. The median age was 66, ranging from 33 to 75 years of age. The majority (26) were men. Treat
 
968 11.9 months Hormone-refractory prostate cancer 4 Chemotherapy
Centro di Riferimento Oncologico Italy 1/2004
Treatment Details: Patients: This Phase II trial involved 28 patients with metastatic hormone-resistant prostate cancer. The median age was 66 years and the median PSA was 135.5 (range from 5.2 – 3940). Elev
 
969 11.9 months Newly diagnosed GBM 5 Chemotherapy
Duke University Medical Center United States 4/2004
Treatment Details: Patients: This Phase II study involved 56 patients with glioblastoma multiforme, 18 with anaplastic astrocytoma, and 2 with anaplastic oligodendroglioma. Patients were either newly diagnose
 
970 11.8 months Newly diagnosed metastatic colorectal cancer 3 Chemotherapy
National Cancer Center Hospital Japan 6/2004
Treatment Details: Patients: This Phase II study involved 38 patients with previously untreated metastatic colorectal carcinoma. Treatment: The treatment consisted of oral fluoropyrimidine S-1 (a combinat
 
Page 97 of 187  | Previous Page  | Next Page